Biodex Balance System in Patients With Parkinson's Disease

February 16, 2024 updated by: Basak Cigdem Karacay, Kirsehir Ahi Evran Universitesi

The Effectiveness of the Exercise Program Applied With the Biodex Balance System in Patients With Parkinson's Disease

Conventional balance exercises are an effective rehabilitation method applied in routine rehabilitation programs for Parkinson's patients. With technological developments, balance exercises

Study Overview

Detailed Description

This study was planned based on the hypothesis that exercises based on visual feedback applied to patients through games will increase patient compliance and improve balance better than conventional exercise.Previous studies have shown that the Biodex balance device has positive contributions to balance in neurological and orthopedic rehabilitation applications.

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • City Center
      • Kırşehir, City Center, Turkey, 40100
        • Recruiting
        • Kırşehir Ahi Evran University Faculty of Medicine
        • Contact:
        • Principal Investigator:
          • Basak Cigdem Karacay, Asist Prof

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Parkinson's diagnosis and Hoehn Yahr stage I-III
  • Not changing medical treatment in the last three months
  • Mini mental test score is over twenty-four

Exclusion Criteria:

  • Vestibular hypofunction
  • Neurological disease other than Parkinson's disease (multiple sclerosis, stroke, myopathy)
  • History of lower extremity surgery (such as arthroplasty, anterior cruciate ligament repair)
  • Upper limb amputation in the participant
  • Impairment in cognitive functions
  • History of psychotic illness
  • Presence of stage 4 gonarthrosis history of malignancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental Group
In addition to conventional balance exercises, the exercise program, which includes games to improve balance, performed with the help of a Biodex balance device, will be given in a total of 20 sessions, 5 days a week, for 4 weeks..
In addition to the conventional exercise program, it will be applied on a platform with the Biodex balance system for 4 weeks, 5 days a week, in a total of 20 sessions.
The conventional balance exercise program will be applied by a physiotherapist for 4 weeks, 5 days a week, in a total of 20 sessions.
Active Comparator: Control Group
The conventional balance exercise program will be applied by a physiotherapist for 4 weeks, 5 days a week, in a total of 20 sessions.
The conventional balance exercise program will be applied by a physiotherapist for 4 weeks, 5 days a week, in a total of 20 sessions.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Berg Balance Scale
Time Frame: Baseline
Berg Balance Scale was developed to measure balance performance and is used to evaluate postural control and predict fall risk. Higher scores indicate better balance
Baseline
Berg Balance Scale
Time Frame: 4th week
Berg Balance Scale was developed to measure balance performance and is used to evaluate postural control and predict fall risk. Higher scores indicate better balance
4th week
Berg Balance Scale
Time Frame: 8 th week
Berg Balance Scale was developed to measure balance performance and is used to evaluate postural control and predict fall risk. Higher scores indicate better balance
8 th week
Biodex dynamic balance score
Time Frame: Baseline
The balance assessment of the participants will be made with the Biodex Balance Systems device. During the measurement, patients will try to stay balanced on the device whose platform stability is adjusted.
Baseline
Biodex dynamic balance score
Time Frame: 4th week
The balance assessment of the participants will be made with the Biodex Balance Systems device. During the measurement, patients will try to stay balanced on the device whose platform stability is adjusted.
4th week
Biodex dynamic balance score
Time Frame: 8th week
The balance assessment of the participants will be made with the Biodex Balance Systems device. During the measurement, patients will try to stay balanced on the device whose platform stability is adjusted.
8th week
The fall efficacy scale
Time Frame: Baseline
The fall efficacy scale consists of 10 questions rated on a 10-point Likert scale. Getting more than 70 points from the scale indicates fear of falling.
Baseline
The fall efficacy scale
Time Frame: 4th week
The fall efficacy scale consists of 10 questions rated on a 10-point Likert scale. Getting more than 70 points from the scale indicates fear of falling.
4th week
The fall efficacy scale
Time Frame: 8th week
The fall efficacy scale consists of 10 questions rated on a 10-point Likert scale. Getting more than 70 points from the scale indicates fear of falling.
8th week
Time up and go test
Time Frame: Baseline
Time up and go testing will be performed to determine fall risk and measure balance, sit-to-stand and walking progress. Minimal detectable change in Parkinson's patients. It is 3.5 seconds. (10.2522/ptj.20090126.)
Baseline
Time up and go test
Time Frame: 4th week
Time up and go testing will be performed to determine fall risk and measure balance, sit-to-stand and walking progress. Minimal detectable change in Parkinson's patients. It is 3.5 seconds. (10.2522/ptj.20090126.)
4th week
Time up and go test
Time Frame: 8th week
Time up and go testing will be performed to determine fall risk and measure balance, sit-to-stand and walking progress. Minimal detectable change in Parkinson's patients. It is 3.5 seconds. (10.2522/ptj.20090126.)
8th week

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The 8-item version of the Parkinson's Disease Questionnaire (PDQ-8)
Time Frame: Baseline
The 8-item version of the Parkinson's Disease Questionnaire (PDQ-8)is a shortened version of the 39-item Parkinson's Disease Questionnaire (PDQ-39). It is a patient-reported outcome measure used to measure people's quality of life. It consists of 8 questions, each question is scored between 0-4. Higher scores indicate worse quality of life.
Baseline
The 8-item version of the Parkinson's Disease Questionnaire (PDQ-8)
Time Frame: 4th week
The 8-item version of the Parkinson's Disease Questionnaire (PDQ-8)is a shortened version of the 39-item Parkinson's Disease Questionnaire (PDQ-39). It is a patient-reported outcome measure used to measure people's quality of life. It consists of 8 questions, each question is scored between 0-4. Higher scores indicate worse quality of life.
4th week
The 8-item version of the Parkinson's Disease Questionnaire (PDQ-8)
Time Frame: 8th week
The 8-item version of the Parkinson's Disease Questionnaire (PDQ-8)is a shortened version of the 39-item Parkinson's Disease Questionnaire (PDQ-39). It is a patient-reported outcome measure used to measure people's quality of life. It consists of 8 questions, each question is scored between 0-4. Higher scores indicate worse quality of life.
8th week
The Five Times Sit to Stand Test
Time Frame: 8th week
The Five Times Sit to Stand Test measures one aspect of transfer skill. The test provides a method to quantify functional lower extremity strength and/or identify movement strategies a patient uses to complete transitional movements. The patient is asked to stand up quickly and sit down 5 times and the time is recorded.
8th week
The Five Times Sit to Stand Test
Time Frame: 4th week
The Five Times Sit to Stand Test measures one aspect of transfer skill. The test provides a method to quantify functional lower extremity strength and/or identify movement strategies a patient uses to complete transitional movements. The patient is asked to stand up quickly and sit down 5 times and the time is recorded.
4th week
The Five Times Sit to Stand Test
Time Frame: baseline
The Five Times Sit to Stand Test measures one aspect of transfer skill. The test provides a method to quantify functional lower extremity strength and/or identify movement strategies a patient uses to complete transitional movements. The patient is asked to stand up quickly and sit down 5 times and the time is recorded.
baseline
Beck Depression Inventory
Time Frame: baseline
Beck depression inventory can be self-scored. It consists of 21 questions. Higher scores indicate increased depression.
baseline
Beck Depression Inventory
Time Frame: 4th week
Beck depression inventory can be self-scored. It consists of 21 questions. Higher scores indicate increased depression.
4th week
Beck Depression Inventory
Time Frame: 8th week
Beck depression inventory can be self-scored. It consists of 21 questions. Higher scores indicate increased depression.
8th week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Basak Cigdem Karacay, Asst Prof, Kirsehir Ahi Evran University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

February 28, 2024

Primary Completion (Estimated)

September 14, 2024

Study Completion (Estimated)

October 14, 2024

Study Registration Dates

First Submitted

February 15, 2024

First Submitted That Met QC Criteria

February 16, 2024

First Posted (Actual)

February 22, 2024

Study Record Updates

Last Update Posted (Actual)

February 22, 2024

Last Update Submitted That Met QC Criteria

February 16, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Parkinson Disease

Clinical Trials on Biodex balance system

Subscribe